Formulation and Characterization of Eudragit-Based Transdermal Patches of Risperidone

Copyright & License

Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{184594,
        author = {Dr. Devinder Maheshwari and Ankit Kumar},
        title = {Formulation and Characterization of Eudragit-Based Transdermal Patches of Risperidone},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {4},
        pages = {3086-3100},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=184594},
        abstract = {},
        keywords = {Risperidone; Olanzapine; Atypical antipsychotics; Transdermal drug delivery system (TDDS); Eudragit RL100/RS100; Permeation enhancers; In vitro and in vivo evaluation; Pharmacokinetics.},
        month = {September},
        }

Cite This Article

  • ISSN: 2349-6002
  • Volume: 12
  • Issue: 4
  • PageNo: 3086-3100

Formulation and Characterization of Eudragit-Based Transdermal Patches of Risperidone

Related Articles